Charles Schwab’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $5.38M | Buy |
|
|||||
|
2022
Q2 | $2.61M | Buy |
|
|||||
|
2022
Q1 | $3.1M | Buy |
|
|||||
|
2021
Q4 | $2.28M | Buy |
|
|||||
|
2021
Q3 | $3.39M | Sell |
|
|||||
|
2021
Q2 | $5.05M | Buy |
|
|||||
|
2021
Q1 | $5.34M | Buy |
|
|||||
|
2020
Q4 | $3.85M | Buy |
|
|||||
|
2020
Q3 | $3.32M | Buy |
|
|||||
|
2020
Q2 | $3.93M | Buy |
|
|||||
|
2020
Q1 | $3.56M | Buy |
|
|||||
|
2019
Q4 | $6.25M | Buy |
|
|||||
|
2019
Q3 | $4.82M | Buy |
|
|||||
|
2019
Q2 | $6.94M | Buy |
|
|||||
|
2019
Q1 | $10.4M | Buy |
|
|||||
|
2018
Q4 | $7.43M | Sell |
|
|||||
|
2018
Q3 | $12.8M | Buy |
|
|||||
|
2018
Q2 | $13.5M | Buy |
|
|||||
|
2018
Q1 | $9.89M | Buy |
|
|||||
|
2017
Q4 | $9.84M | Buy |
|
|||||
|
2017
Q3 | $7.42M | Buy |
|
|||||
|
2017
Q2 | $7.27M | Buy |
|
|||||
|
2017
Q1 | $6.17M | Buy |
|
|||||
|
2016
Q4 | $5.1M | Buy |
|
|||||
|
2016
Q3 | $3.99M | Buy |
|
|||||
|
2016
Q2 | $661K | Buy |
|
|||||
|
2016
Q1 | $363K | Hold |
|
|||||
|
2015
Q4 | $727K | Hold |
|
|||||
|
2015
Q3 | $530K | Buy |
|
|||||
|
2015
Q2 | $524K | Buy |
|
|||||
|
2015
Q1 | $502K | Hold |
|
|||||
|
2014
Q4 | $468K | Hold |
|
|||||
|
2014
Q3 | $332K | Hold |
|
|||||
|
2014
Q2 | $397K | Buy |
|
|||||
|
2014
Q1 | $238K | Hold |
|
|||||
|
2013
Q4 | $202K | Buy |
|